Home » Topics » BioWorld Science

BioWorld Science
RSS

iRhom2 is fibrosis friend, not foe

Nov. 5, 2019

Gene therapy can treat, prevent heart failure

Nov. 5, 2019

Broad strategy for HIV bnAbs

Nov. 5, 2019

Dopamine goes from pleasure to repair molecule

Nov. 5, 2019

Neuronal insulin resistance linked to age-related dementia

Nov. 4, 2019

RP-7214: a novel DHODH inhibitor with oral activity in preclinical AML models

Nov. 4, 2019

VCP inhibitors patented by University of Pittsburgh

Nov. 4, 2019

HIV replication inhibitors detailed in ViiV Healthcare patent

Nov. 4, 2019

Erytech announces new milestones in TRYbeCA1 phase III study of eryaspase

Nov. 4, 2019

Enanta Pharmaceuticals identifies compounds for RSV infections

Nov. 4, 2019

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...